Skip to main content
Livermore
Livermore
ZHEN

Ossiam

SEC CIK
0001767471
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Ossiam, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
45,879
Value
$22.8M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Ossiam, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202645,879$22.8M0.3%+6,522+16.6%AddedHolders
Q1 202639,357$17.6M0.3%+21,763+123.7%AddedHolders
Q4 202517,594$7.98M0.2%+4,654+36.0%AddedHolders
Q3 202512,940$5.07M0.1%+8,340+181.3%AddedHolders
Q2 20254,600$2.05M<0.1%−66,608−93.5%ReducedHolders
Q1 202571,208$34.5M0.5%+6,375+9.8%AddedHolders
Q4 202464,833$26.1M0.5%+435+0.7%AddedHolders
Q3 202464,398$30.0M0.6%−1,107−1.7%ReducedHolders
Q2 202465,505$30.7M0.6%+54,411+490.5%AddedHolders
Q1 202411,094$4.64M0.1%+2,100+23.3%AddedHolders
Q4 20238,994$3.66M0.1%+1,238+16.0%AddedHolders
Q3 20237,756$2.70M<0.1%+227+3.0%AddedHolders
Q2 20237,529$2.65M<0.1%−91,574−92.4%ReducedHolders
Q1 202399,103$31.2M0.6%+3,044+3.2%AddedHolders
Q4 202296,059$27.7M0.7%+1,765+1.9%AddedHolders
Q3 202294,294$27.3M0.8%−1,764−1.8%ReducedHolders
Q2 202296,058$27.1M0.8%+1,984+2.1%AddedHolders
Q1 202294,074$24.6M0.6%+4,020+4.5%AddedHolders
Q4 202190,054$19.8M0.5%+87,369+3,254.0%AddedHolders
Q3 20212,685$487.0K<0.1%+393+17.1%AddedHolders
Q2 20212,292$462.0K<0.1%−2,676−53.9%ReducedHolders
Q1 20214,968$1.07M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.